The latest in health it & security: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Oracle Health data breach exposes sensitive pat....
Roche Puts Up $100M to Pursue Promising But Competitive New Target in Obesity
Roche gains global rights to a Rona Therapeutics RNA interference drug designed to target ALK7, a genetically validated target for obesity and other metabolic indications. The growing field of companies pursuing ALK7 includes GSK and Arrowhead Pharmaceuticals. The post Roche Puts Up $100M to Pursue Promising But Competitive New Target in Obesity appeared first on MedCity News.
J&J’s medtech business slows again in Q3
For the second straight quarter, the cardiovascular unit experienced slower sales growth due to ongoing struggles in the Abiomed business.
Follow the full firehose on the HTC Wire, refreshed automatically every day.